Momentum Life Sciences Receives Strategic Growth Investment From Parthenon Capital

Parthenon Capital Makes Strategic Investment in Embark

September 4, 2025

Consulting

Parthenon Capital has made a strategic growth investment in Embark, a Dallas-based management and financial consulting firm, to accelerate the company's organic growth and M&A strategy while expanding its technology and AI capabilities. Founder Paul Allen will remain Chairman and retain a significant ownership stake as Embark pursues investments in automation, AI, talent, and expanded advisory services.

Parthenon Capital Invests in AArete

June 24, 2025

Consulting

Parthenon Capital has made a strategic growth investment in AArete, a Chicago-based management and technology consulting firm specializing in profitability improvement and digital transformation for healthcare payers, financial services and the public sector. The capital will be used to accelerate growth initiatives, broaden AArete’s service offerings, and support acquisitions while existing employees and leaders remain significant shareholders.

Parthenon Capital Acquires Majority Stake in Titan Wealth

February 21, 2023

Wealth Management

Parthenon Capital has acquired a majority stake in Titan Wealth, partnering with the management team to support further organic growth, technology investment and future M&A. The transaction delivers a partial exit for Maven's UK Regional Buyout Fund (with a material return) while existing investors including funds managed by Ares and Maven remain committed to the business.

Kohlberg & Company Recapitalizes Trinity Life Sciences

November 30, 2021

Healthcare Services

Kohlberg & Company will recapitalize Trinity Life Sciences, replacing Parthenon Capital as the company’s capital partner. The transaction provides Trinity with new growth capital to support global expansion, technology and data-driven capability investments while Trinity’s management team, led by CEO David Fitzhenry, will remain in place.

Parthenon Capital Completes Growth Recapitalization of Nuvem Health

July 22, 2020

Healthcare Services

Parthenon Capital has completed a growth recapitalization investment in Nuvem Health, a healthcare technology company that provides pharmacy claims administration and analytics for safety-net healthcare providers. Proceeds will be used to accelerate growth initiatives and provide liquidity to non-management shareholders while Nuvem's senior leadership, including Founder & President Colleen DiClaudio and CEO Gonen Antebi, remain in place.

Parthenon Capital Invests in RxSense

May 12, 2020

Healthcare Services

Parthenon Capital, a growth-oriented private equity firm, has made a significant growth investment in RxSense to support the company's expansion and product development. Proceeds will be used for growth initiatives as RxSense scales its pharmacy benefits technology platform and consumer prescription savings solutions.